Abstract Library

#2794 Pancreatic Neuroendocrine Tumor (pNET) Showing Remission after Tuberculostatic Treatment – An Unusual Case Report Suggesting Anti-Proliferative Effects of Antibiotics in pNETs

Introduction: Several classes of antibiotics have been associated with anti-proliferative effects on cancer cells; however, there is no data on this regarding pNETs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Kiesewetter B

Authors: Kiesewetter B, Lagler H, Mazal P, Kretschmer-Chott E, Haug A,

Keywords: pancreatic neuroendocrine tumors, treatment, somatostatin analogs, antibiotics, lanreotide,

#1903 Hypoglycemias Appearing in a Patient Suffering from Poorly Differentiated Neuroendocrine Tumor for Three Years.

Introduction: Insulinomas are the most common functional PNENs and they have a weak malignant potential (<10%)

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Deslé M, Dermine A, Grandjean M, Seront E, Lejeune S,

Keywords: neuroendocrine neoplasm, insulinoma, hypoglycemia,

#1273 Tissue Prognostic Markers in Pancreatic Neuroendocrine Tumours

Introduction: Pancreatic neuroendocrine tumours (pNETs) are a rare, heterogeneous class of neoplasms, with a rising incidence. Prognosis is variable with 5-year survival as low as 16% in inoperable tumours.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Dunbar J

Authors: Dunbar J, Tod J, Horne J, Armstrong T, Cave J,

Keywords: Pancreatic, microenvironment, prognosis,

#1148 Ki67 as a Prognostic Marker in Neuroendocrine Tumours: A Systematic Review of the Literature and Quantitative Synthesis of 5 year Survival Data

Introduction: The ENETS guidelines classify Gastroenteropancreatic Neuroendocrine Tumours (GEP NETs) according to the histological assessment of tumour mitotic count or Ki67 labelling index (LI) on paraffin-embedded tissue, because proliferation rate has been shown to strongly correlate with prognosis. Since the guidelines were published, Ki67 has been established as the more reproducible measure, and further large case series have been reported.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Cave J

Authors: Richards-Taylor S, Tilley C, Hu J, Pearce N, Armstrong T,

Keywords: GEP-NET, prognosis, Ki67,

#1144 Aggressive Multi-Modality Treatment of Pancreatic Neuroendocrine Tumors (pNETs): Outcomes in Patients with Advanced Disease

Introduction: pNETs carry the worst prognosis of all NETs, particularly when hepatic metastasis are present. We try to actively treat all patients referred.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Mayo D

Authors: Mayo D, Armstrong T, Cave J, Nolan L, Steadman B,

Keywords: pNET, multimodal, Neuroendocrine,